Amelie Brebion

Amelie Brebion is a Researcher at the Microorganisms Laboratory: Genome Environment, University Clermont Auvergne (UCA), where she contributes to cutting-edge virology research as a permanent academic staff member. Her work focuses on SARS-CoV-2 pathogenesis and diagnostic development, with significant institutional affiliation to UCA's research infrastructure.

Her primary research interests encompass virology and immunology, specifically examining SARS-CoV-2 variant dynamics (Delta, Omicron), longitudinal antibody responses post-vaccination, and viral contamination risks in human reproductive fluids. Methodologically, she specializes in RT-PCR assay validation and genomic sequencing, bridging clinical microbiology with reproductive health through rigorous molecular diagnostics. This interdisciplinary approach addresses critical pandemic response challenges while advancing understanding of viral transmission pathways.

Dr. Brebion's 2021-2023 publications reveal concentrated research on SARS-CoV-2 variants, demonstrating increasing antibody protection post-booster (2023), documenting co-infections during variant co-circulation (2022), and validating semen contamination detection methods (2022). These works, published in Emerging Microbes & Infections, Clinical Microbiology and Infection, and Reproductive BioMedicine Online, establish her expertise in viral genomics and diagnostic innovation within pandemic contexts.

Scientific Awards: No awards mentioned in available documentation.

Advising and Grants: No information available regarding student supervision or research funding sources.

Laboratory Affiliation: As a core member of the Microorganisms Laboratory: Genome Environment, Dr. Brebion collaborates on projects investigating pathogen-environment interactions, with current emphasis on viral genomics, infectious disease epidemiology, and translational diagnostic development for emerging pathogens.